Clariant CLN.SW (SIX) +3.09% to CHF8.00 intraday 25 Feb 2026: margins key
Clariant AG (CLN.SW) is trading at CHF8.00, up 3.09% intraday on 25 Feb 2026 as investors position ahead of full-year results due 26 Feb 2026. The CLN.SW stock move follows a volume of 814,498 and shows short-term momentum versus the 50-day average of CHF7.47. Today’s price action compresses the gap to the 200-day average CHF7.85, and the market will key on margin trends and guidance that management is expected to deliver.
CLN.SW stock: earnings timeline and what to expect
Clariant reports results on 26 Feb 2026 after market close, with the company flagging continuing strength in specialty additives and catalysts. One clear expectation is a pickup in EBIT margin given FY2024 EBIT growth of 63.87% year-over-year. Analysts will watch organic sales, margins in Care Chemicals and Catalysis, and any changes to FY2026 guidance.
CLN.SW stock: financials, valuation and key ratios
Clariant’s trailing EPS is 0.34 with a trailing PE of 23.53, and market capitalization about CHF2626284888.00. Price-to-sales is 0.65 and price-to-book is 1.38, suggesting the market values the company modestly above book. Free cash flow yield is 6.82%, and dividend per share is 0.42, implying a yield near 5.25% on current levels.
Meyka AI rates CLN.SW with a score out of 100 and forecast
Meyka AI rates CLN.SW with a score out of 100: 68.44 (B) and the platform suggests HOLD. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a near-term target of CHF9.00, an implied upside of 12.50% versus the current CHF8.00. Forecasts are model-based projections and not guarantees.
CLN.SW stock: what will move the price on the print
Management commentary on margin drivers and cost pass-through will be decisive, especially for Catalysis and Care Chemicals. Expect markets to react to: (1) organic sales growth rate, (2) EBIT margin surprise versus consensus, (3) working capital guidance given days sales outstanding near 60.28, and (4) any update on debt reduction given net-debt-to-EBITDA roughly 3.05x.
CLN.SW stock: technicals and intraday trading context
Technically, RSI sits at 54.83, MACD histogram slightly negative and ADX 22.57, indicating a mild trend with room for follow-through. Today’s range has tested the middle Bollinger band at CHF7.95; a sustainable move above CHF8.86 (upper band) would open a run toward the year high CHF11.18. Average daily volume near 848,481 supports liquidity for larger orders.
CLN.SW stock: sector comparison and risk points
Clariant sits in the Basic Materials sector where average PE is 18.55 for comparable chemical firms; Clariant’s PE of 23.53 embeds higher growth expectations. Key risks include higher raw material costs, delayed pass-through, and net debt strain given debt-to-equity 1.07. Sector momentum is mixed; investors should weigh dividend yield against cyclical exposure.
Final Thoughts
Key takeaways for CLN.SW stock ahead of earnings: first, price action at CHF8.00 up 3.09% shows investors already bidding for positive margin news. Second, core financials show EPS 0.34, PE 23.53, free cash flow yield 6.82%, and dividend 0.42 that supports income-minded holders. Third, Meyka AI’s score of 68.44 (B, HOLD) balances recent operating improvements with elevated leverage and cyclical revenue patterns. Note that Meyka AI’s forecast model projects CHF9.00, implying +12.50% upside from today’s price; forecasts are model-based projections and not guarantees. Traders should watch margins, working capital signals and guidance language on 26 Feb 2026. For quick access to the quote and news, see the Clariant page on Meyka and the latest market write-up on Bloomberg. Meyka AI is an AI-powered market analysis platform providing real-time signals and scoring for CLN.SW stock.
FAQs
When does Clariant report earnings and why does it matter for CLN.SW stock?
Clariant reports after market close on 26 Feb 2026. The print matters because margins, guidance and cash conversion will determine whether CLN.SW stock sustains today’s intraday gains and the direction into the next quarter.
What is Meyka AI’s short-term forecast for CLN.SW stock?
Meyka AI’s forecast model projects CHF9.00 as a near-term target, implying about 12.50% upside from CHF8.00. Forecasts are model-based and not guarantees; investors should combine them with company results and guidance.
Which metrics should investors watch in the report for CLN.SW stock?
Focus on reported EBIT margin, organic sales growth, free cash flow and guidance on working capital given DSO near 60.28. Also monitor commentary on cost pass-through and any plans to reduce net debt.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.